A North American, single-center experience implanting fenestrated atrial devices and atrial flow regulators into a heterogeneous group of pediatric pulmonary hypertension patients
IntroductionThe clinical deterioration commonly experienced by pediatric patients with pulmonary arterial hypertension (PAH) has motivated a shift in the treatment of pulmonary hypertension (PH) through innovations in surgical salvage interventions. The Occlutech fenestrated atrial septal defect (FA...
Saved in:
Main Authors: | David Edward Youssef (Author), Konstantin Averin (Author), Susan Richards (Author), Catherine Sheppard (Author), Cameron Seaman (Author), Matthew Pietrosanu (Author), Angela Bates (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Canadian, retrospective, multicenter experience with selexipag for a heterogeneous group of pediatric pulmonary hypertension patients
by: David Youssef, et al.
Published: (2023) -
Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience
by: David Edward Youssef, et al.
Published: (2023) -
Experience with the largest custom-made 48 mm fenestrated atrial septal occluder device and its 4-year follow-up
by: Kothandam Sivakumar, et al.
Published: (2023) -
Transcatheter reduction in size of large undesirable fenestrations following extracardiac conduit Fontan surgery with off-label use of Occlutech atrial flow regulator
by: Bhushan Shivaji Sonawane, et al.
Published: (2020) -
Outcomes of Device Closure of Atrial Septal Defects
by: P. Syamasundar Rao
Published: (2020)